Assembly Biosciences Stock Forward View - Simple Moving Average
| ASMB Stock | USD 26.09 1.27 4.64% |
Assembly Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Assembly Biosciences stock prices and determine the direction of Assembly Biosciences's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Assembly Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Assembly Biosciences' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Assembly Biosciences hype-based prediction, you can estimate the value of Assembly Biosciences from the perspective of Assembly Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Assembly Biosciences on the next trading day is expected to be 26.73 with a mean absolute deviation of 1.04 and the sum of the absolute errors of 61.66. Assembly Biosciences after-hype prediction price | USD 26.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Assembly Biosciences to cross-verify your projections. Assembly Biosciences Additional Predictive Modules
Most predictive techniques to examine Assembly price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Assembly using various technical indicators. When you analyze Assembly charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Assembly Biosciences Simple Moving Average Price Forecast For the 13th of February 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Assembly Biosciences on the next trading day is expected to be 26.73 with a mean absolute deviation of 1.04, mean absolute percentage error of 1.80, and the sum of the absolute errors of 61.66.Please note that although there have been many attempts to predict Assembly Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Assembly Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Assembly Biosciences Stock Forecast Pattern
| Backtest Assembly Biosciences | Assembly Biosciences Price Prediction | Research Analysis |
Assembly Biosciences Forecasted Value
In the context of forecasting Assembly Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Assembly Biosciences' downside and upside margins for the forecasting period are 22.93 and 30.52, respectively. We have considered Assembly Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Assembly Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Assembly Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.0245 |
| Bias | Arithmetic mean of the errors | 0.2528 |
| MAD | Mean absolute deviation | 1.045 |
| MAPE | Mean absolute percentage error | 0.0335 |
| SAE | Sum of the absolute errors | 61.655 |
Predictive Modules for Assembly Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Assembly Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Assembly Biosciences After-Hype Price Density Analysis
As far as predicting the price of Assembly Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Assembly Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Assembly Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Assembly Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Assembly Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Assembly Biosciences' historical news coverage. Assembly Biosciences' after-hype downside and upside margins for the prediction period are 22.66 and 30.26, respectively. We have considered Assembly Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Assembly Biosciences is not too volatile at this time. Analysis and calculation of next after-hype price of Assembly Biosciences is based on 3 months time horizon.
Assembly Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Assembly Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Assembly Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Assembly Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 3.80 | 0.00 | 0.02 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
26.09 | 26.46 | 1.42 |
|
Assembly Biosciences Hype Timeline
Assembly Biosciences is presently traded for 26.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Assembly is expected to increase in value after the next headline, with the price projected to jump to 26.46 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 1.42%, whereas the daily expected return is presently at -0.49%. The volatility of related hype on Assembly Biosciences is about 11176.47%, with the expected price after the next announcement by competition of 26.11. The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (40.18 M) with loss before overhead, payroll, taxes, and interest of (24.65 M). Given the investment horizon of 90 days the next expected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Assembly Biosciences to cross-verify your projections.Assembly Biosciences Related Hype Analysis
Having access to credible news sources related to Assembly Biosciences' direct competition is more important than ever and may enhance your ability to predict Assembly Biosciences' future price movements. Getting to know how Assembly Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Assembly Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZURA | Zura Bio Limited | 0.00 | 0 per month | 4.14 | 0.13 | 9.32 | (5.80) | 33.15 | |
| FHTX | Foghorn Therapeutics | 0.00 | 0 per month | 3.40 | 0.04 | 8.60 | (5.56) | 31.12 | |
| IMRX | Immuneering Corp | 0.00 | 0 per month | 0.00 | (0.02) | 8.98 | (5.64) | 67.18 | |
| SGMT | Sagimet Biosciences Series | 0.00 | 0 per month | 0.00 | (0.15) | 5.78 | (8.25) | 22.02 | |
| ENTA | Enanta Pharmaceuticals | 0.00 | 0 per month | 2.85 | 0.06 | 5.67 | (3.78) | 15.79 | |
| AARD | Aardvark Therapeutics Common | 0.34 | 4 per month | 4.36 | 0.08 | 9.35 | (8.66) | 38.95 | |
| NAUT | Nautilus Biotechnology | 0.00 | 0 per month | 4.58 | 0.06 | 9.29 | (7.62) | 28.35 | |
| ARCT | Arcturus Therapeutics Holdings | 0.00 | 0 per month | 3.37 | (0.01) | 6.53 | (5.23) | 15.98 | |
| PYXS | Pyxis Oncology | 0.00 | 0 per month | 0.00 | (0.14) | 9.23 | (15.41) | 66.31 | |
| TNYA | Tenaya Therapeutics | 0.00 | 0 per month | 0.00 | (0.11) | 9.02 | (10.71) | 48.07 |
Other Forecasting Options for Assembly Biosciences
For every potential investor in Assembly, whether a beginner or expert, Assembly Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Assembly Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Assembly. Basic forecasting techniques help filter out the noise by identifying Assembly Biosciences' price trends.Assembly Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Assembly Biosciences stock to make a market-neutral strategy. Peer analysis of Assembly Biosciences could also be used in its relative valuation, which is a method of valuing Assembly Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Assembly Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Assembly Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Assembly Biosciences shares will generate the highest return on investment. By undertsting and applying Assembly Biosciences stock market strength indicators, traders can identify Assembly Biosciences entry and exit signals to maximize returns.
| Accumulation Distribution | 6139.93 | |||
| Daily Balance Of Power | (0.77) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 26.29 | |||
| Day Typical Price | 26.22 | |||
| Price Action Indicator | (0.83) | |||
| Period Momentum Indicator | (1.27) |
Assembly Biosciences Risk Indicators
The analysis of Assembly Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Assembly Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting assembly stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.86 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.43 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Assembly Biosciences
The number of cover stories for Assembly Biosciences depends on current market conditions and Assembly Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Assembly Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Assembly Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Assembly Biosciences Short Properties
Assembly Biosciences' future price predictability will typically decrease when Assembly Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Assembly Biosciences often depends not only on the future outlook of the potential Assembly Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assembly Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6 M | |
| Cash And Short Term Investments | 112.1 M |
Check out Historical Fundamental Analysis of Assembly Biosciences to cross-verify your projections. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.